Thomas M. Habermann, Author at Renal and Urology News

Thomas M. Habermann

All articles by Thomas M. Habermann

Intravascular large B-cell lymphoma

Intravascular large B-cell lymphoma What every physician needs to know: Intravascular large B-cell lymphoma (IVLBCL) is a rare form of an extranodal malignant non-Hodgkin lymphoma (NHL) that involves the growth of lymphoma cells within the lumina of capillaries, small arteries and small veins which plug these vessels. The diagnosis is characteristically established on extranodal tissue.…

Diffuse large B cell lymphoma

Diffuse large B cell lymphoma What every physician needs to know: Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma that is potentially curable. DLBCL is the most common non-Hodgkin lymphoma (NHL) representing about 25-35% of all new cases of NHL in the United States of America (USA) and Europe. The disease can manifest de…

Intravascular large B-cell lymphoma

Intravascular large B-cell lymphoma What every physician needs to know: Intravascular large B-cell lymphoma (IVLBCL) is a rare form of an extranodal malignant non-Hodgkin lymphoma (NHL) that involves the growth of lymphoma cells within the lumina of capillaries, small arteries and small veins which plug these vessels. The diagnosis is characteristically established on extranodal tissue.…

Diffuse large B cell lymphoma

Diffuse large B cell lymphoma What every physician needs to know: Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma that is potentially curable. DLBCL is the most common non-Hodgkin lymphoma (NHL) representing about 30% of all cases of NHL in the United States of America (USA) and Europe. There are over 76 different types…

Next post in Oncology